Koss-Olinger Consulting, LLC

Position in JNJ — Johnson & Johnson

CIK 1861163 GAINESVILLE, FL

Position in JNJ

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$418,796

-$49,551 QoQ

Shares Held

1,649

-13.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#3,881

of 4,676 holders

Holding Since

Mar 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Koss-Olinger Consulting, LLC holds $866,167 across 3 Drug Manufacturers - General names. JNJ ranks #1 (48.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	1,649	$418,796
2	GSK	GSK plc	4,370	$229,075
3	LLY	ELI LILLY & Co	182	$218,296

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$418,796	1,649	-13.9%	Shares	Sole	2026-08-10
2026-03-31	$468,347	1,916	-63.9%	Shares	Sole	2026-05-07
2025-12-31	$1,098,904	5,310	-19.1%	Shares	Sole	2026-02-10
2025-09-30	$1,217,282	6,565	0.0%	Shares	Sole	2025-10-20
2025-06-30	$1,002,803	6,565	-3.7%	Shares	Sole	2025-08-01
2025-03-31	$1,130,531	6,817	+25.5%	Shares	Sole	2025-05-12
2024-09-30	$880,634	5,434	+16.4%	Shares	Sole	2024-10-21
2024-06-30	$682,421	4,669	-15.9%	Shares	Sole	2024-08-06
2023-12-31	$869,750	5,549	-17.0%	Shares	Sole	2024-02-13
2023-06-30	$1,107,163	6,689	-1.0%	Shares	Sole	2023-07-31
2023-03-31	$1,047,335	6,757	+131.6%	Shares	Sole	2023-05-12
2022-12-31	$515,288	2,917	-14.7%	Shares	Sole	2023-02-14
2022-09-30	$558,854	3,421	+2.7%	Shares	Sole	2022-11-14
2022-06-30	$591,463	3,332	-26.3%	Shares	Sole	2022-07-08
2022-03-31	$801,611	4,523	-13.1%	Shares	Sole	2022-05-06
2021-12-31	$890,077	5,203	-9.5%	Shares	Sole	2022-02-07
2021-09-30	$928,140	5,747	-38.8%	Shares	Sole	2021-11-09
2021-06-30	$1,547,238	9,392	-6.8%	Shares	Sole	2021-08-11
2021-03-31	$1,655,661	10,074	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.